Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (201-210 of 576) with videos related to

Pageof 58
Sort By:
The American Journal of Medicine|February 4, 2014
Survival after community diagnosis of early-stage non-small cell lung cancerNorma F Kanarek, Craig M Hooker, Luckson Mathieu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2023
De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling PathwaysSubhamoy Chakraborty, Charles Coleman, Parvathy Manoj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancerCharles M Rudin, Mark Kozloff, Philip C Hoffman, et al.
Oncogene|March 10, 2015
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2J T Poirier, E E Gardner, N Connis, et al.
NMR in Biomedicine|May 18, 2001
Current awarenessN Beckmann, C Gentsch, D Baumann, et al.
Health Physics|December 13, 2005
Calculation of dose coefficients for radionuclides produced in a spallation neutron source utilizing NUBASE and the evaluated nuclear structure data file databasesJ Shanahan, K Eckerman, A Arndt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived XenograftsJames Laird, Benjamin H Lok, Brandon Carney, et al.
Health Physics|December 13, 2005
Quality assurance methods and procedures used to verify consistency in calculating dose coefficientsA Arndt, J Shanahan, C Gold, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancerJerome D Winegarden, Ann M Mauer, Thomas F Gajewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2009
Lung cancer in never smokers: clinical epidemiology and environmental risk factorsJonathan M Samet, Erika Avila-Tang, Paolo Boffetta, et al.
Pageof 58

Showing results (201-210 of 576) with videos related to

Sort By:
Pageof 58
The American Journal of Medicine|February 4, 2014
Survival after community diagnosis of early-stage non-small cell lung cancerNorma F Kanarek, Craig M Hooker, Luckson Mathieu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2023
De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling PathwaysSubhamoy Chakraborty, Charles Coleman, Parvathy Manoj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancerCharles M Rudin, Mark Kozloff, Philip C Hoffman, et al.
Oncogene|March 10, 2015
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2J T Poirier, E E Gardner, N Connis, et al.
NMR in Biomedicine|May 18, 2001
Current awarenessN Beckmann, C Gentsch, D Baumann, et al.
Health Physics|December 13, 2005
Calculation of dose coefficients for radionuclides produced in a spallation neutron source utilizing NUBASE and the evaluated nuclear structure data file databasesJ Shanahan, K Eckerman, A Arndt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived XenograftsJames Laird, Benjamin H Lok, Brandon Carney, et al.
Health Physics|December 13, 2005
Quality assurance methods and procedures used to verify consistency in calculating dose coefficientsA Arndt, J Shanahan, C Gold, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancerJerome D Winegarden, Ann M Mauer, Thomas F Gajewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2009
Lung cancer in never smokers: clinical epidemiology and environmental risk factorsJonathan M Samet, Erika Avila-Tang, Paolo Boffetta, et al.
Pageof 58